Spoken Alpha
INSULET CORP
Insulet Corporation manufactures and sells the Omnipod platform, a tubeless, wearable insulin delivery system for people with insulin-dependent diabetes. The Omnipod 5 features an automated insulin delivery algorithm that integrates with continuous glucose monitors, while Omnipod DASH offers manual insulin delivery via smartphone control.
INSULET CORP is a Healthcare company operating in Medical Devices with a $9.56B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
22 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PODD.
$ curl https://api.spokenalpha.com/v1/companies/PODDFAQ
Spoken Alpha indexes PODD's earnings call transcripts at https://spokenalpha.com/companies/PODD. Each call links to attributed speakers and parsed analyst Q&A. INSULET CORP's own investor relations page is at https://investor.insulet.com/overview/default.aspx.
INSULET CORP (PODD) held its most recent earnings call on 2026-08-05, covering fiscal Q2 2026.
INSULET CORP (PODD) operates in the Healthcare sector (Medical Devices industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $1.59 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-04 | $1.66 | $1.44 | +15.3% | $801.7M | — | — | EODHD |
| Q1 FY2026 | 2026-05-05 | $1.42 | $1.19 | +19.3% | $761.7M | — | — | EODHD |
| Q4 FY2025 | 2026-02-17 | $1.55 | $1.48 | +4.7% | $783.8M | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $1.24 | $1.15 | +7.8% | $706.3M | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $1.17 | $0.93 | +25.8% | $649.1M | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $1.02 | $0.79 | +29.1% | $569.0M | — | — | EODHD |
| Q4 FY2024 | 2025-02-19 | $1.15 | $1.02 | +12.6% | $597.5M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.90 | $0.76 | +18.4% | $543.9M | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $0.55 | $0.56 | -1.8% | $488.5M | — | — | EODHD |
| Q1 FY2024 | 2024-05-08 | $0.73 | $0.39 | +87.2% | $441.7M | — | — | EODHD |
| Q4 FY2023 | 2024-02-21 | $1.40 | $0.66 | +100.0% | $509.8M | — | — | EODHD |
| Q3 FY2023 | 2023-11-01 | $0.71 | $0.41 | +73.2% | $432.7M | — | — | EODHD |
| Q2 FY2023 | 2023-08-07 | $0.38 | $0.26 | +46.2% | $396.5M | — | — | EODHD |
| Q1 FY2023 | 2023-05-03 | $0.23 | $0.10 | +100.0% | $358.1M | — | — | EODHD |
| Q4 FY2022 | 2023-02-22 | $0.24 | $0.21 | +14.3% | $369.7M | — | — | EODHD |
| Q3 FY2022 | 2022-11-02 | $0.41 | $0.14 | +100.0% | $340.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-03 | $-0.08 | $0.23 | -100.0% | $299.4M | — | — | EODHD |
| Q1 FY2022 | 2022-05-04 | $0.40 | $0.24 | +66.7% | $295.4M | — | — | EODHD |
| Q4 FY2021 | 2022-02-22 | $0.42 | $0.32 | +31.3% | $307.7M | — | — | EODHD |
Source: EODHD. PODD reported actuals as published; sparse fields render as —.